Equities

Sri Trang Gloves (Thailand) PCL

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Sri Trang Gloves (Thailand) PCL

Actions
Health CareMedical Equipment and Services
  • Price (THB)9.15
  • Today's Change0.00 / 0.00%
  • Shares traded7.03m
  • 1 Year change+22.00%
  • Beta1.0164
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sri Trang Gloves (Thailand) Public Company Limited is a Thailand-based manufacturer of examination and industrial gloves. The Company's businesses include manufacturing and distribution of natural rubber gloves, and manufacturing and distribution of nitrile butadiene rubber gloves. Its main products are natural rubber powdered gloves (NRPD), natural rubber powder free gloves (NRPF) and nitrile butadiene rubber gloves (NBR). The Company produces and distributes natural and nitrile rubber gloves both in Thailand and abroad. The main markets of the Company include Asian countries, the United States of America, Europe, and South America. It has two distribution channels for both domestic and international customers, namely the distribution of rubber gloves under the trademark of the Company and its subsidiaries, and OEM contract manufacturing as rubber gloves under the trademark of the Company and its subsidiaries, and rubber gloves under OEM contracted manufacturing.

  • Revenue in THB (TTM)25.40bn
  • Net income in THB951.95m
  • Incorporated2019
  • Employees10.93k
  • Location
    Sri Trang Gloves (Thailand) PCL17th Floor, Park VentureEcoplex Unit 1701, 1707-1712No. 57 Wireless Road, Lumpini, PathumwanBANGKOK 10330ThailandTHA
  • Phone+66 22074500
  • Fax+66 21082241
  • Websitehttps://www.sritranggloves.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jiangsu Bioperfectus Technologies Co Ltd1.52bn-116.73m25.46bn592.00--1.91--16.70-0.3096-0.30964.0435.380.09031.856.13572,683.70-0.691920.36-0.79624.5558.2262.71-7.6631.893.22--0.132928.76-13.293.9099.46---9.88--
Yidu Tech Inc3.35bn-400.32m25.48bn823.00--1.48--7.61-0.0954-0.09540.79624.120.159524.781.341,023,371.00-2.03-24.00-2.38-30.0834.4135.64-12.72-123.004.37--0.0321---11.415.0839.58--26.45--
Qingdao NovelBeam Technology Co Ltd2.57bn783.76m25.52bn841.0032.624.31--9.931.451.454.7610.990.38170.99325.67679,901.1011.3912.7012.6114.1164.3463.1529.8433.963.4351.040.105840.95-5.9011.86-7.1113.4813.44--
Shanghai INT Medical Instruments Co Ltd4.14bn805.23m25.53bn2.01k25.192.5220.766.161.211.216.2212.070.38022.0511.49601,027.707.988.4610.149.8160.9960.3421.0024.360.96626.740.225324.3113.1724.3615.6312.6817.46--
Shanghai Aohua Phtlctrcty Endscp Co Ltd3.02bn-325.42m25.59bn1.22k--4.57--8.48-0.5475-0.54755.109.250.38341.022.29552,775.60-4.143.01-5.153.3461.7968.86-10.807.521.57--0.208643.3010.5420.28-63.68-16.8623.29--
BrainAurora Medical Technology Ltd767.28m-946.61m25.91bn174.00--21.68--33.77-0.1881-0.18810.15250.22140.3274--1.241,214,328.00-40.54---112.29--41.26---123.83-----10.130.6324--82.01--44.78------
China Isotope & Radiation Corp34.31bn1.91bn26.19bn3.36k13.721.155.020.76331.501.5026.9917.990.51863.141.752,563,965.006.226.3112.9912.9948.2655.5411.9911.951.5168.900.27530.1614.1613.689.624.3311.8123.56
Sri Trang Gloves (Thailand) PCL25.40bn951.95m26.22bn10.93k26.520.68537.951.030.34510.34519.0013.350.54685.429.552,323,680.002.0518.462.3420.889.2936.783.7528.011.627.130.115658.7627.1415.82551.879.43-16.95--
PHC Holdings Corp74.02bn720.23m26.29bn9.04k37.190.81014.290.355227.4327.432,861.021,259.090.66233.405.2440,253,730.000.60380.1061.120.161745.2546.910.91170.17380.36061.640.6084916.512.175.81181.3214.73-1.83--
Shenzhen Lifotronic Technology Co Ltd4.74bn1.13bn26.30bn1.67k23.112.78--5.550.59070.59072.474.900.38552.515.74631,202.608.9814.0312.1017.3461.0362.4623.3027.253.00--0.140639.010.202422.125.1227.99-1.6318.64
Hangzhou Biotest Biotech Co Ltd2.15bn461.12m27.03bn603.0057.812.57--12.560.69640.69643.0615.660.19133.205.70793,854.104.0223.634.2526.2050.5756.5921.0041.4713.08--0.0000834.4226.5321.7859.0143.1244.08--
AK Medical Holdings Ltd6.23bn1.33bn27.56bn1.00k20.652.2415.184.430.29880.29881.402.760.4111.062.661,642,495.008.778.0110.899.6959.2763.0121.3420.182.88--0.074722.5723.087.7650.420.51418.660.1873
Data as of Feb 16 2026. Currency figures normalised to Sri Trang Gloves (Thailand) PCL's reporting currency: Thai Baht THB

Institutional shareholders

2.87%Per cent of shares held by top holders
HolderShares% Held
LGT Bank (Singapore) Ltd.as of 21 Apr 202561.53m2.15%
Krungsri Asset Management Co., Ltd.as of 30 Sep 20259.97m0.35%
Dimensional Fund Advisors LPas of 05 Feb 20263.12m0.11%
SCB Asset Management Co., Ltd.as of 30 Sep 20252.60m0.09%
Bangkok Capital Asset Management Co. Ltd.as of 30 Sep 20251.26m0.04%
Krung Thai Asset Management Public Co., Ltd.as of 30 Sep 20251.16m0.04%
PGIM Quantitative Solutions LLCas of 31 Dec 20251.02m0.04%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025631.12k0.02%
Eastspring Asset Management (Thailand) Co., Ltd.as of 30 Sep 2025592.51k0.02%
Kasikorn Asset Management Co., Ltd.as of 30 Sep 2025450.71k0.02%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.